The 2020 holiday season was unlike any other as the risks of COVID-19 remained too high for families to safely celebrate together. A year later, precautions to slow the spread of the virus and, of course, the availability ...
Nov 15, 2021
0
2
As COVID-19 cases balloon again in Europe, the World Health Organization called Friday for more targeted vaccination efforts to ensure the most vulnerable worldwide get the jabs.
Nov 12, 2021
0
2
Pancreatic cancer forms in the cells of the pancreas, an organ in the abdomen that releases enzymes that aid digestion and produces hormones that help manage our blood sugar levels. Pancreatic cancer is a rare disease with ...
Nov 11, 2021
0
1
Patients with advanced renal cell carcinoma who received the checkpoint inhibitor combination nivolumab (Opdivo) plus ipilimumab (Yervoy) experienced longer treatment-free survival (TFS) over a 42-month period than patients ...
Nov 10, 2021
0
2
Suicide risk among lesbian, gay, and bisexual adults varies considerably depending on the intersection between sexual identity and other aspects of identity, such as gender, age, and race/ethnicity, according to a study led ...
Nov 9, 2021
0
0
November is Pancreatic Cancer Awareness Month, which makes this a good time to learn more about the risk factors for pancreatic cancer and what you can do to keep yourself safe.
Nov 4, 2021
0
5
(HealthDay)—Sotrovimab reduces the risk for disease progression in high-risk patients with mild-to-moderate COVID-19, according to a study published online Oct. 27 in the New England Journal of Medicine.
Oct 29, 2021
0
6
(HealthDay)—An advisory panel to the U.S. Centers for Disease Control and Prevention will meet on Wednesday to discuss which Americans, if any, should get Pfizer booster shots to rev up their immunity to COVID-19.
Sep 22, 2021
0
0
Data sets that are biased by having too many genomes from people with European ancestry can still be applied to other ancestry groups to predict their risk of developing breast and prostate cancer. Lars Fritsche of the University ...
Sep 16, 2021
0
36
As part of the NIH-sponsored ACTIV-2 clinical trial for COVID-19 outpatients, preliminary data revealed that a new combination monoclonal antibody treatment reduced hospitalizations and death by 78 percent in high-risk patients. ...
Sep 1, 2021
0
19
